Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bone Histomorphometry Assessment For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease

NCT00261950 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT00261950
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00261950 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bone Histomorphometry Assessment For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease
Lead sponsor
Amgen
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2006
Completion date
May 31, 2011
Enrollment
110 (actual)
Sites
55

Conditions

As the registry lists them; a condition with its own page is linked.

secondary hyperparathyroidism